PALO ALTO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)TO PROVIDE ADVOCACY DEDICATED TO PROMOTING LIFESAVING STEM CELL RESEARCH AND THERAPY DEVELOPMENT.
PROVIDED ADVOCACY DEDICATED TO PROMOTING LIFE-SAVING STEM CELL RESEARCH AND THERAPY DEVELOPMENT. STAFF MADE AVAILABLE TECHNICALLY CORRECT SCIENTIFIC AND POLICY-RELATED INFORMATION AND MATERIALS TO...
PROVIDED ADVOCACY DEDICATED TO PROMOTING LIFE-SAVING STEM CELL RESEARCH AND THERAPY DEVELOPMENT. STAFF MADE AVAILABLE TECHNICALLY CORRECT SCIENTIFIC AND POLICY-RELATED INFORMATION AND MATERIALS TO THE PUBLIC, INDIVIDUALS AND THEIR STAFFS VIA OUR WEBSITEAND OUTREACH. MATERIALS INCLUDED INFORMATION ABOUT KEY STEM CELL AND THERAPY DEVELOPMENTS, AS WELL AS THE POTENTIAL IMPLICATIONS OF "PERSONHOOD" LEGISLATION FOR IN-VITRO FERTILIZATION (IVF), STEM CELL RESEARCH, AND OTHER AREAS. CONTINUED TO HELP COMMUNICATING TO THECALIFORNIA PUBLIC ABOUT THE SUCCESSES OF CIRM AND ITS GRANTEES AROUND CALIFORNIA.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | N/A | N/A | N/A |
| Expenses | N/A | N/A | N/A |
| Net Income | N/A | $0 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERT N KLEIN II | CHAIRMAN OF THE BOARD | 0.02 |
Officer
Director
|
$0 | $0 | $0 |
| DON REED | SECRETARY/TREASURER | 0.77 |
Officer
Director
|
$0 | $0 | $0 |
| BERNARD SIEGEL | BOARD MEMBER | 0.01 |
Director
|
$0 | $0 | $0 |
| ROBERT N KLEIN III | BOARD MEMBER | 0.05 |
Director
|
$0 | $0 | $0 |
| ALYSSA G KLEIN | BOARD MEMBER | 0.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | No data | No data | $255 | No data |
| 2022 | No data | No data | $255 | No data |
| 2021 | $1,172,211 | $132,861 | $255 | $1,039,350 |
| 2020 | No data | $10 | $255 | No data |
| 2019 | $500,000 | $500,000 | $265 | No data |
Compare AMERICANS FOR STEM CELL THERAPIES AND CURES with other nonprofits in California and across the country.